--- a
+++ b/clusters/3009knumclusters/clust_39.txt
@@ -0,0 +1,836 @@
+Platelets >= 75 x 10^9/L within 30 days of day 1 of study
+Platelets >= 100,000/ul
+Platelets >= 100 x 10^3/uL
+Platelets >= 100,000/ul
+Platelets >= 100 x 10^9/L within 14 days prior to registration.
+Platelets >= 100,000
+Platelets >= 100,000/ul
+Platelets >= 75,000 g/uL
+Platelets >= 100,000 cells/uL (75 x 10^9 L); and,
+Platelets >= 100,000/uL
+Platelets >= 100 X 10^9/L
+Platelets >= 100 x 10^9/L.
+Platelets >= 100,000/ul (within 14 days of treatment initiation)
+Platelets >/= 100 × 109/L
+Platelets >= 100,000/ul
+Platelets >= 100 x 10^9/L
+Platelets ? 100 × 109/L
+Platelets ? 100,000/uL
+Platelets ? 100,000/mL
+Platelets >= 100 x 10^9/L
+Platelets ?100 x 109/L
+Platelets ?75,000 µL
+Platelets >= 100,000/uL
+Platelets >= 75 x 10^9/L
+Platelets >= 100 × 10^9/L
+Platelets (Plt) >= 30,000 x 10^9/L
+Platelets >= 100,000/uL
+Platelets >= 100 x 10^9/L
+Platelets >= 100 x 10^9/L
+Platelets >= 100 x 10^9/L
+Platelets >= 100,000/uL
+Platelets >= 75,000/ul
+Platelets >= 100 K/uL
+Platelets ? 75,000/ul
+Platelets ?100,000 ?L.
+Platelets >= institutional lower limit
+Obtained within 14 days prior to C1D1: Platelets >= 100,000 4/uL
+Platelets ?100 × 10?9/L;
+Platelets 100,000/ul or more
+Obtained =< 21 days prior to registration: platelets (PLT) >= 50,000/uL
+Platelets >= 75,000/uL
+Platelets >= 100,000/uL
+platelets: ? 100 x 109/L
+Platelets >= 100 x 10^9/L
+Platelets >= 100 K/uL
+Platelets >= 75,000/uL
+Platelets < 100,000/µL
+Platelets >= 100 K/uL
+Platelets >= 100 x 10^9/L
+Platelets >= 100,000/uL
+Documented within 14 days of registration: Platelets >= 75,000/ul (unsupported)
+Platelets >= 100 x 10^9/L, determined within 14 days of registration
+Within 28 days of study registration: Platelets >= 100 x 10^9/L
+Platelets >= 100 K/uL
+Platelets >= 100,000/microliter
+Platelets ? 75 x 10^9/L Chemistry:
+Platelets ? 100,000/uL within 28 days prior to registration
+Platelets ? 60 K/uL
+Platelets >= 100,000/L
+Platelets >= 75 x 10^9/L, at the screening visit
+Platelets >= 100 x 10^9 (without platelet transfusion)
+Platelets ? 75,000/?L
+Platelets >= 100,000/mL
+Platelets ?100×109/L (w/o transfusions w/in 21 days)
+Within 14 days prior to registration: Platelets >= 100,000/uL
+Platelets <100 x 109/L
+Platelets >= 50,000/uL; a subject will not be excluded because of pancytopenia related to disease
+Platelets >= 75 x 10^3/uL
+Platelets (PLT) >= 100,000/uL
+Platelets >= 100 x 10^9/L
+Platelets >= 100,000 cells/ul
+Platelets ?75 x 109/L
+INCLUSION - TREATMENT: Platelets > 50,000/ul
+Platelets >= 75,000 total
+Platelets >= 100 X 10^9/L
+Platelets >= 100,000 cells/ul
+Platelets >= 100,000/uL
+Platelets >= 100,000/uL
+Platelets >= 100,000/uL
+Platelets >= 100 x 10^9/L
+Platelets >= 75 K/uL
+Platelets >= 100,000/uL
+Platelets >= 75,000
+Thrombocytopenia (platelets [Plt] < 100,000/ul)
+Platelets >= 100 x 10^9/L
+Platelets >= 100,000/uL within 14 days prior to first dose of protocol-indicated treatment.
+Platelets >= 100 × 10^9/L.
+Within 14 days of the first dose of study drug: Platelets >= 100 x 10^3/uL
+Platelets >= 100 x 10^9/L
+Platelets > 70,000/uL
+Platelets >= 100 x 10^9/L
+Within 10 days prior to the start of study treatment: Platelets >= 100 000/uL
+Platelets ? 75,000/microliter
+Platelets >= 100 x 10^3/uL.
+Within 28 days prior to registration: Platelets >= 100 x 10^9/L
+Platelets >= 100,000/uL
+Platelets > 50,000/uL.
+Platelets ? 20,000/uL
+Platelets >= 100 x 10^3/uL
+Platelets >= 75,000/microliter
+Platelets ? 100 x 109/L
+Platelets >= 100 k/uL
+Obtained within 14 days prior to randomization/registration: platelets >= 100 x 10^3/uL
+Platelets >= 100,000/dl
+Platelets ? 100,000/uL
+Platelets >= 75,000/ uL, within 2 weeks of registration
+Platelets >= 50,000/uL
+Platelets >= 75,000 cells/uL
+Platelets >= 100,000/ul
+Platelets (PLT) ? 100
+Platelets >= 100,000/uL
+Platelets > 100,000/uL
+Platelets 100,000/ul or more
+Platelets > 100,000/ul
+Platelets >= 100,000/ul
+Platelets 100,000/ul or more
+Platelets >= 100,000/ul.
+Platelets >= 60,000/Ul.
+Platelets >= 100 K/UL
+Platelets (plt) >= 100 x 10^9/L
+Platelets ? 100 x 10^9/L
+Platelets >= 100,000 x 10^9 /L
+Platelets >= 100,000/uL
+Platelets >= 100,000/ul (unsupported)
+Platelets >= 125,000 cells/ul (prior to biopsy)
+Within 14 days of the first dose of the study drugs: Platelets >= 75,000/L.
+Platelets >= 100,000/uL.
++ 0 for (platelets <50), +1 for (platelets >50).
+Platelets >= 100,000/uL
+Within 28 days prior to enrollment: Platelets >= 100,000/uL
+Obtained within 21 days prior to randomization/registration: Platelets >= 100 x 10^3/uL.
+Platelets >= 100 x 10^9/L
+Platelets >= 100 x 10^9/L (For patients with hepatocellular carcinoma, platelets >= 70 x 10^9/L).
+Platelets < 100 x 10^9/L
+No more than 14 days prior to registration: Platelets >= 100,000/uL
+Platelets >= 50,000/uL
+Performed within 14 days of treatment initiation: Platelets >= 100,000/uL
+Platelets >= 100 x 10^9/L
+Platelets > 10 x 10^9/L
+Platelets >= 100,000/ul
+Platelets >= 100 x 10^9/L
+Platelets >= 150,000/ul
+Platelets >= 100,000/uL
+Platelets >= 75,000/ L
+Platelets (plts) > 100 x 10^9/L
+Platelets > 100 x 10^9/L
+Platelets >= 100,000/uL
+Platelets >= 100 x 10^9/L
+Platelets > 100 x 10^9/L without transfusion
+Platelets >= 100,000/uL
+Platelets >= 100 x 10^3/uL
+Platelets >= 100,000/ uL, within 2 weeks of registration (except where specified otherwise)
+Platelets (PLT) >= 100 x 10^3/uL, within 30 days before study registration
+Platelets >= 75,000/uL
+(For both cohorts A and B): Platelets >= 100 x 10^9/L
+Platelets >= 100,000 /uL
+Platelets ? 75,000/µl
+Platelets >= 100,000/uL
+Platelets =< 100,000/uL
+Platelets >= 100x10^3/uL
+Platelets >= 75,000/uL
+Platelets >= 100,000/uL obtained < 4 weeks prior to starting treatment
+Platelets >= 75 x 10^9/L
+Platelets >= 100 x 10^9/L
+Platelets ? 75 x 109/L
+Platelets >= 75,000
+Obtained within 14 days of randomization: Platelets >= 100 x 10^3/uL
+Platelets >= 100,000/mL.
+Platelets >= 100,000/ul
+Platelets >= 100 x 10^9/L
+Platelets >= 100,000 cells/ml
+Platelets >= 100 x 10^9/L
+Platelets >= 75 X 10^9/L
+Platelets >= 100 X 10^3/uL
+Platelets < 100,000 cells/uL
+Platelets >= 100 x 10^9/L
+Platelets >= 75,000 per microliter
+Platelets >= 100,000/uL
+Platelets >= 100 x 10^9/L
+Platelets >= 100,000/uL within 14 days prior to study entry
+Platelets >= 100 x 10^9/L
+Platelets >= 100 x 10^9/L
+Platelets >= 100 x 10^3/uL
+Platelets >= 100,000/uL (performed within 28 days of registration)
+Platelets >= 100 X 10^9/L
+Platelets >= 75 x 10^3/uL should be obtained within 21 days prior to enrollment
+Platelets >= 80 x 10^9/L
+Platelets >= 75,000/uL at screening visit
+Platelets >= 100 x 10^9/L
+Platelets >= 75,000/uL at screening visit
+Platelets >= 100 x 10^9/L
+Platelets =< 50,000
+Platelets ? 100 × 10^9/L
+Platelets >= 60,000/uL performed within 7 days of treatment initiation
+Platelets > 75,000/uL
+Platelets < 100 x 10^9 /L
+Platelets >= 75,000 cells/uL
+Platelets >= 100,000/uL
+Platelets >= 100 x 10^3 /uL
+Platelets < 100,000/mL
+Platelets >= 100,000/mL
+Platelets >= 100,000 x 10^9/L
+Platelets >= 100 x 10^9/L:\r\n* Unless due to bone marrow infiltration then eligible if platelets > 50 x 10^9/L)
+Platelets > 70,000/uL
+Platelets >= 75,000
+Platelets >= 100 x 10^9/L
+Platelets >= 50,000/uL
+Platelets >= 75,000/dL
+Platelets >= 100 x 10^9/L
+Platelets ? 100,000/?L
+Platelets >= 100,00/uL
+Platelets >= 100,000 per uL
+Platelets >= 100 x 10^3/uL
+Platelets > 100,000/uL
+Platelets >= 100,000/uL
+Platelets >= 100 x 10^9/L
+Platelets < 20,000/ul prior to treatment
+Platelets > 75,000/L
+Platelets >= 100 x 10^9/L
+Platelets >= 50 x 10^9/L (without transfusion support)
+Platelets >= 100,000
+Platelets >= to 100,000 /uL
+Platelets >= 100,000/mL
+Platelets ? 100 x 109 cells/L
+Platelets ? 100000/L
+Platelets >= 50,000/uL
+Platelets >= 100,000/uL
+platelets ? 100x10^9/L
+Platelets (PLT) >= 75 x 10^9/L without transfusions
+Platelets >= 100,000/ul, (75,000/ul if due to bone marrow [BM] involvement)
+Platelets >= 100,000/uL obtained within 14 days of first treatment
+Platelets ? 100 x 109/L.
+Platelets >= 100 x10^3/uL obtained within 14 days prior to randomization/registration
+Platelets >= 100,000 x 10^9/L
+Platelets >= 100,000/µL
+Within 14 days prior to registration: Platelets >= 100,000 x 10^9/L
+Platelets ? 100,000/?l
+Platelets >= 100,000 cells/ul
+Platelets >= 100 x 10^9/L
+Platelets >= 100 x 10^3/uL
+Platelets >= 100,000/uL
+Platelets >= 75 x 10^9/L
+Platelets >= 100,000/uL
+Platelets >= 100,000/mL
+Platelets ? 75,000/?L
+Platelets >= 75 x 10^9/L
+Platelets >= 100 x 10^9/L
+Platelets > 100000 within 30 days of consent
+Platelets > 100000 within 45 days of consent
+Platelets > 100 x 10^9/L within 14 days of study entry
+Platelets >= 100 x 10^9/L
+Platelets ? 150,000 x 10^6 cells/L
+Documented platelets >= 80,000
+Platelets >= 100 x 10^3/uL
+Platelets >= 100,000/ul
+Platelets >= 100,000/uL
+Platelets >= 80 x 10^9/L
+Platelets < 100 x 10^9/L
+Platelets > 100,000/ul (transfusion independent)
+Platelets >= 100,000/uL
+Platelets <100 x 109/L
+Platelets >= 100,000/microliter
+Platelets >= 100k
+Platelets >= 75 x 10^9/L
+Platelets (Plts) >= 100,000 /uL
+Platelets > 100,000/ul
+Platelets >= 100 x 10^9/L, obtained within 30 days of study registration
+Platelets >= 75 K
+Platelets >= 100 x 10^9/L
+Platelets >= 100,000/uL within 14 days of the first dose of study drug
+Platelets >= 100,000/dl
+Platelets >= 100 x 10^9/L
+Platelets > 100,000 cells/ul
+platelets ? 100 x 10^9/L
+Platelets >= 75 k/uL
+Platelets >= 100 x 10^9/L
+Platelets >= 50 x 10^9/L
+Platelets >= 50,000 x 10^9/L
+Platelets >= 100 x 10^9/L
+Platelets > 100 x 10^9/L
+Platelets >= 100,000/uL
+Platelets >= 100 x 10^9/L
+Platelets >= 50 x K/uL
+Platelets >= 100,000/ul
+Platelets >= 100 x 10^9/L
+Platelets >= 100,000 cells/ul
+Platelets >= 75 x 10^3/uL
+Within 14 days prior to registration: Platelets >= 100 x 10^9/L
+Platelets > 75 x 10^9/L
+Platelets >= 100,000/µL
+Platelets >= 100 x 10^9/L
+Platelets >= 100,000/ul
+Platelets > 50 k/ul
+Platelets > 100,000/ul (transfusion independent)
+Platelets >= 50 x 10^9/L
+Platelets >= 75,000/uL (within 2 weeks prior to radiotherapy)
+ANC >/=1 x10(9)/L and platelets >/=100 x10(9)/L.
+Platelets >= 120,000/uL
+Platelets (PLT) >= 100,000 uL
+Platelets > 50,000/uL
+Platelets >= 100 x 10^9/L
+Platelets >= 100,000 /uL
+Platelets (Plt) >= 75,000
+Platelets >= 100,000 per uL
+Platelets >= 100 x 10^3/uL
+Platelets >= 100,000/uL
+Platelets >= 50,000/mL
+Platelets >= 100 x 10^9/L
+Platelets >= 75,000/mL
+Platelets >= 75,000/mL
+Platelets > 75,000/uL
+Platelets >= 100 x 10^9/L
+Platelets >= 100 x 10^9/L (transfusion dependent)
+Platelets >= 100,000/mL
+Platelets >= 100,000/uL (non-transfused)
+Platelets =< 75,000/ul
+Platelets >= 100 x 10^9/L
+Platelets >= 100K
+Platelets > 100,000/ul (transfusion independent)
+Platelets >= 100,000/ul
+Platelets > 100,000
+Platelets > 100,000/ul
+Platelets > 50 x 10^9/L without transfusion in the prior 7 days
+Platelets ? 100 x 109/L
+Platelets ? 100,000/µL
+platelets ? 100,000/?L,
+Platelets >= 70,000 /uL
+Platelets ? 100,000/µL (?100 x 10^9/L)
+Platelets > 50 x 10^9/L
+Platelets <100 X 109/L
+Platelets ? 100,000/?L
+Platelets (PLT) >= 100,000
+Platelets >= 100 x 10^3/ul
+Platelets >= 100 x 100/L
+Platelets ? 100 x 109/L
+Platelets >= 100,000/uL
+Platelets >= 100,000.
+Platelets >= 100,000/uL
+Platelets ? 75 x 109 cells/L
+Platelets >= 100,000/microliter
+Platelets (PLT) >= 100 x 10^9/L without transfusions
+Platelets >= 100,000/mL
+Platelets >= 100,000/mL
+Platelets >= 100 x 10^9/L
+Platelets >= 100 × 10^9/L =< 14 days prior to registration
+Platelets (PLT) >= 100,000/uL
+Platelets >= 100,000
+Platelets >= 100 x 10^9/L
+Platelets >= 100 x 10^9/L
+Platelets > 100 x 10^9/L
+Platelets >= 100 x 10^9 / L
+Platelets >= 100 x 10^9/L
+Platelets >= 100,000/ul
+Platelets >= 75 x 10^9/L
+Platelets >= 100 x 10^9/L
+Platelets >= 100 x 10^9/L
+Platelets >= 100,000/uL
+Platelets >= 100,000/uL
+TUMOR BIOPSY SEQUENCING: Platelets >= 100,000/uL (mcL)
+Platelets >= 100 x10^3/uL
+Platelets 100,000/ul or more
+Platelets >= 100 x 10^9/L
+Platelets >= 100 x 10^9/L
+Platelets > 100,000/uL
+Platelets >= 75,000/uL
+Platelets >= 10 x 10^9/L
+Secondary Registration: platelets >= 100,000/uL
+Platelets >= 100 x 10^9/L
+Platelets >= 100,000/uL
+Platelets (PLT) >= 100,000/uL
+Platelets > 100,000/uL
+Platelets > 50,000/ul
+Platelets > 50,000/uL
+Platelets >= 100,000/uL (untransfused)
+Platelets (PLT) >= 100,000/uL
+Platelets >= 100 x 10^3/uL
+Platelets >= 100,000/uL
+Platelets >= 100,000/uL
+Platelets >= 90 x 10^3/uL
+Platelets >= 100 × 10^9/L
+Platelets >= 100,000/ul
+Platelets >= 100 × 10^9/L
+Platelets >= 100 x 10^9/L
+Within 14 days of subject registration: Platelets 100,000/uL (no transfusion allowed within 2 weeks)
+Platelets > 150,000
+Platelets >= 100,000/uL
+Platelets >= 100,000/ul
+Platelets >= 100,000/uL
+Platelets >= 100,000/uL
+Platelets >= 100,000/uL
+Platelets >= 100,000/uL
+Platelets > 50,000 per microliter
+Platelets >= 100 x10^9/L
+Platelets >= 50 x 10^9/L
+Platelets >= 100 x 10^9/L, within 2 weeks of the first dose of study treatment
+Platelets >= 100 x 10^9/L
+Platelets >= 50,000
+Hematologic criteria: ANC <  500/uL, Platelets < 25,000 uL.
+Platelets >= 100 x 10^9/L
+Platelets (PLT) >= 100,000/ul
+Platelets >= 100 x 10^3/uL
+Platelets >= 100,000/uL
+Platelets >= 100 x 10^9/L
+Platelets >= 100,000/uL
+Platelets > 50k/ul
+Platelets >= 100 x 10^3/uL
+Platelets >= 100 x 10^3/uL
+Platelets >= 100,000/mL
+Platelets >= 100,000/ml
+Platelets >= 50,000/uL
+Platelets > 100,000/ul
+Platelets > 100 x 10^9/L without transfusion
+Thrombocytopenia (platelets [Plt] < 100,000/ul)
+Platelets >= 100 x 10^9/L
+Platelets >= 100,000/uL
+Platelets (plt) ? 100 x 109/L,
+Performed within 14 days of patient registration: Platelets >= 100,000/uL (no transfusion allowed within 2 weeks)
+Platelets >= 100,000/ul
+Platelets > 75,000/uL
+Platelets >= 100 x 10^9/L.
+Platelets >= 75 x 10^3/uL
+Platelets (PLT) >= 100,000
+Platelets > 100,000/uL
+Platelets < 75,000
+Platelets >= 160,000/ul
+Platelets ? 75 x10?/L
+Platelets ?100,000/uL (microliter)
+Platelets ? 100,000 cells/ml,
+Platelets >100,000/mL (without platelet transfusion within the last 2 weeks)
+Platelets ? 100 x 10^9/L
+Platelets ? 30 x 10^3/uL
+Platelets > 90 x 10^9/L
+Platelets ? 60 x 109/L.
+Platelets (plt) ? 100 x 109/L.
+Platelets (Plt) ?100 x 109/L.
+Platelets >= 100,000/ul
+Platelets >= 100 x 10^3/uL
+Platelets >= 100 x 10^3/uL
+Platelets >= 75 x 10^3/uL
+Platelets >= 100 x 10^9/l
+Platelets >= 100,000/ul
+Platelets ?100,000/?L
+Platelets < 100x109/L
+Platelets ?100,000 / mL
+Platelets (PLT) <75 x 109/L (75x103/µL)
+Platelets > 100,000/ul
+Platelets >= 100 x 10^9/L
+Platelets >= 100,000/uL
+Platelets ? 75 x 103/?L
+Platelets >= 100,000/uL
+Platelets < 100000/ml
+Platelets >=100,000/uL.
+Platelets >= 100 x 10^9/L
+Platelets >= 75,000/ul
+Platelets: >= 100,000/uL
+Platelets >= 100 x 10^9/L
+Platelets >= 100 x 10^9/L
+Platelets >= 100 x 10^3/uL
+Platelets >= 100,000/uL
+Platelets > 100,000/uL
+Platelets >= 75,000/uL
+Platelets >= 100,000/L
+Platelets > 100,000/?L
+Platelets >= 75,000/microliter
+Platelets >= 100 x 10^9/L
+Platelets (PLT) >= 100,000/uL
+Platelets >= 100,000/uL
+Platelets >= 50000/uL
+Platelets >= 100,000 /uL
+Platelets > 75,000/µl
+Platelets >= 100 x 10^9/L
+Platelets (PLT) > 75,000/ul
+Platelets of > 100 x 10^9/L
+Platelets >= 100,000/ul (untransfused)
+Platelets >= 100 x 10^9/L.
+Platelets >= 100,000
+Platelets >= 100,000/uL obtained =< 7 days prior to randomization
+Platelets >= 75 x 10^9/L
+Platelets > 100 x10^3/uL
+Platelets < 100000/ml
+Platelets >= 50,000/uL
+Platelets >= 100,000/uL
+Platelets >= 200 x 10^9/L
+Platelets >= 50,000/uL
+Platelets (Plt) > 100
+Platelets >= 100,000/uL
+Platelets >= 75 x 10^3/uL
+Platelets ? 100 x 10^9 cells/L
+Platelets >= 100 X 10^9/L
+Platelets > 100,000/uL
+Within 4 weeks of administration of study therapy: Platelets >= 100,000/uL
+Platelets >= 20,000 without platelet transfusion
+Platelets < 50,000 x 10^9/L.
+Platelets >= 75 x 10^9/L, performed within 28 days of treatment initiation
+Platelets >= 100 x 10^3/uL
+Platelets < 50,000/ul
+Platelets >= 100,000/ul
+Platelets >= 100x10^9/L
+Platelets >= 125,000 cells/ul
+Platelets (plt) >= 100 x 10^9/L
+Platelets ? 100 x 10?/L
+Platelets (PLT) >= 50,000 mL
+Platelets >= 160 x 10^9/L
+Platelets >= 100,000/mL
+Platelets >= 100 x 10^9/L
+Obtained =< 21 days prior to registration: Platelets (PLT) >= 50,000/uL
+Platelets >= 100,000/?L
+Platelets >= 100 x 10^9/L
+Platelets >= 100,000/uL
+Platelets >= 100,000/ul
+Platelets >= 100 × 10^3/uL
+Platelets >= 100 x 10^9/L
+Platelets>=100 x 10^9/L
+Platelets >= 50,000/uL
+Platelets ? 75,000/?L
+Platelets >= 50,000 cells/uL within 14 days before enrollment
+Platelets >= 100 x 10^9/L
+Platelets ?100,000/?L
+Platelets >= 75 x 10^3/uL
+Platelets >= 75 x 10^3/uL
+Platelets >= 100,000/mL
+Platelets ?75000/µL
+Platelets >= 100,000/ul
+Platelets ? 75 × 109/L.
+AT THE TIME OF INFUSION: Platelets > 50,000/ul
+Platelets >= 100,000/uL
+Platelets >= 100,000/uL
+Platelets >= 100,000/mL
+Platelets >= 100,000/uL
+Platelets =< 50,000
+Platelets ?100 x 10^9/L.
+COHORT A: Platelets >= 75 x 10^3/uL
+COHORT B: Platelets >= 75 x 10^3/uL
+Platelets >= 100 X 10^9 cells/L
+Platelets ? 100,000/µL
+Platelets >= 100,000 ml
+Platelets >= 100,000/ul (unsupported)
+Platelets (PLT) >= 100,000 / uL
+Platelets >= 90 x 10^3/uL
+Platelets > 100,000
+Platelets > 75,000/uL
+Platelets >= 50,000/ul
+Platelets >= 100 x 10^9/L
+Platelets >= 75,000/uL
+Platelets (PLT) >= 100,000/uL
+Platelets >= 100 x 10^9/L
+Platelets >= 100 x 10^9/L
+Platelets >= 100,000/ul
+Platelets >= 50,000 cells/uL (50 x 10^9/L)
+Platelets >= 100,000/ul (no transfusion allowed within 2 weeks)
+Platelets >= 100,000/uL
+Platelets (plt) >= 100 x 10^9/L
+Platelets >= 75,000/uL
+Platelets >= 100 x 10^9/L
+Platelets >= 100 K/UL
+Platelets >= 100 X 10^9/L
+Platelets > 100,000/µL
+Platelets >= 100,000 per uL
+Platelets >= 100 x 10^9/L
+Platelets >= 100 x 10^9/L
+Platelets (plt) >= 100 x 10^9/L
+Platelets ? 100 x 10^9/L
+Platelets ? 100 x 10^9/L.
+Platelets >= 50,000/mL
+Platelets >= 100,000/uL
+Platelets >= 50,000/uL
+Platelets >= 100 x 10^9/L
+Platelets >= 100,000/uL
+Platelets >= 50,000/uL
+Platelets >= 75 x 10^9/L
+Platelets >= 100,000/uL
+Platelets (PLT) =< 100K
+Platelets ? 100 x 109/L
+Platelets >= 75 x 10^9/L
+Platelets < 75 x 10^9/L
+Platelets >= 100,000/uL
+Platelets >= 100 x 10^9/L
+Platelets < 50 x 10^9/L
+Platelets >= 50,000 (50 x 10^9/L)
+Platelets >= 100,000/uL
+Platelets >= 75,000 per uL
+Platelets >= 100,000/ul
+Platelets < 100,000 /uL
+Platelets > 80,000
+Low platelets (< 75 k/ul)
+Platelets >= 100 x 10^3/uL
+Platelets >= 100,000
+Platelets >= 50,000/mL
+Platelets >= 100 X 10^9/L
+Platelets >= 100,000/uL
+Platelets >= 100,000/Ul
+Platelets > 100,000/uL prior to day 0
+Platelets >= 100 x 10^9/L
+Platelets > 75,000/uL
+Platelets >= 100,000/uL
+Platelets >= 100 X 10^9/L
+Platelets > 50,000 (platelet transfusion allowed)
+The patient has an absolute neutrophil count (ANC) ?1000/µL, platelets ?100,000/µL and is not transfusion dependent for platelets and/or red cells
+Platelets > 100,000/mL
+Within 14 days after subjects signed the treatment consent: Platelets >= 100,000/ul
+Platelets >= 50 x 10^3/uL
+Platelets >= 100,000/uL
+Platelets >= 100 x 10^9/L (without transfusion < 14 days before enrollment)
+Platelets >= 100 x 10^3/uL
+Platelets (PLT) >= 75,000/ul
+Platelets >= 100 X 10^9/L
+Platelets: >= 75 x 10^3/uL (~ 75 x 10^9/L)
+Platelets >= 100,000/uL
+Platelets >= 100 x 10^9/L
+Platelets >= 100 X 10^9/L
+Platelets >= 100,000/uL
+Platelets > 100 x 10^9/L
+Platelets >= 100 x 10^9/L
+Platelets >= 100,000/uL
+Platelets > 100 K
+Platelets >= 100,000/uL, within 14 days of registration
+Platelets >= 100 x 10^9/L
+Platelets > 100,000/ul
+Platelets >= 100 x 10^9 cells/L
+Platelets >= 100,000/?L
+Platelets >= 100,000/uL
+Platelets >= 100 x 10^9/L
+Platelets >= 50,000/mL
+Platelets >= 100,000
+Platelets >= 100,000/ul
+Platelets >= 100 x 10^9/L (must be independent of platelet transfusion)
+Platelets >= 30,000/uL
+Platelets >= 75,000/ul
+Platelets >= 50,000/mL
+SORAFENIB ARM: platelets >= 75,000/mL
+Platelets > 50,000
+Platelets >= 75 x 10^9/L
+Platelets >= 100 x 10^3/uL
+Platelets >= 100,000/uL
+Within 14 days prior to enrollment/randomization: Platelets >= 100,000/uL
+Platelets ? 75,000/?L (without intervention, e.g., transfusion)
+Platelets >= 50,000/uL
+Platelets >= 50,000/mL
+Platelets >= 100,000 cells/ul
+Platelets > 50,000/uL
+Platelets > 50,000/uL
+Platelets >= 50,000 uL
+PRIOR TO POST-TRANSPLANT IMMUNOTHERAPY: Platelets > 50,000/uL
+Platelets > 100,000/ul
+Platelets >= 100,000/ul (unless low platelets are due to multiple myeloma)
+Platelets > 100,000/ul
+Platelets (PLT) >= 50,000/uL
+Platelets > 75,000 cells/ul
+Platelets of at least 75,000 x 106/L
+Platelets of 75K
+Platelets >= 100 x 10^9/L
+Platelets > 100 x 10^9/uL
+Platelets (PLT) > 100,000/ml
+Platelets (PLT) >= 100 x 10^9/L without transfusions
+Platelets >= 100,000/uL
+Platelets < 100,000/ml
+Platelets >= 80 x10^9/L
+Platelets >= 100,000//uL
+Platelets >= 100,000/uL
+Platelets >= 75,000
+Platelets: >= 75 x 10^3/uL (~75 x 10^9/L)
+Platelets < 100 x 109/L
+Platelets >= 100,000/uL
+Platelets >= 50,000 cells/uL, or >= 30,000/uL if bone marrow is involved by malignancy
+Platelets ?100,000/?L
+Platelets ? 100
+Platelets >= 50 X 10^9/L
+Platelets (PLT) >= 100,000
+Platelets ? 50 X 10³/µL
+Platelets >= 50.0 x 10^9/L
+Platelets > 100,000/uL
+Platelets ? 100,000//microL
+Platelets >= 100,000/uL
+Platelets >= 100,000/ul
+Platelets ? 100,000/µL (? 100 x 103/µL)
+Platelets >= 100,000/ul
+Platelets >= 100 x 10^9/L
+Platelets ?100,000/?L;
+Platelets >= 80,000 x 10^9/L
+Platelets <75,000/?L
+Platelets > 50,000/uL
+Platelets >= 100 x 10^9/L
+Platelets >= 75 K/uL (transfusions are permissible)
+Platelets >= 100 x 10^9/L
+Platelets: >= 75,000/ul
+Platelets >= 100 x 10^3/uL
+Platelets >= 100,000 /uL without transfusion within 10 days prior to dose
+Platelets >= 100,000/uL
+Platelets ?75,000 /mL
+Platelets >= 75,000/uL
+Platelets ? 100 × 10³/µL
+Platelets >= 75,000/uL
+Platelets >= 100,000
+Platelets (plt) >= 100 x 10^9/L
+Platelets ? 75,000 /mL;
+Platelets >= 50,000
+Platelets >= 50,000
+Platelets >= 100 x 10^9/L
+Platelets ? 100 × 109/L;
+Platelets >= 75,000
+Platelets >= 50000/uL
+Platelets ? 100 x 10^9, Hb ? 90 g/L, ANC ? 1.5 x 10^9/L.
+Platelets >= 100,000/ul
+Platelets >= 100 x 10^9/L
+Platelets >=100,000/uL
+Platelets (PLT) >= 100 x 10^9/L without transfusions
+Platelets >=100x10^9/L
+Platelets >= 100,000/uL
+Platelets >= 100 x 10^9/L
+Platelets >= 100,000 x 10^9/L
+Platelets > 75 x 10^9/L
+Platelets >= 100,000/ul
+Platelets >= 100 x 10^9/L
+Platelets >= 100 x 10^9/L
+Platelets > 50,000/uL not supported by transfusions
+Platelets >= 100,000/ul
+Platelets >= 100,000/uL
+Platelets ? 100,000/µL
+Platelets >= 100,000/?L
+Platelets >= 100 x 10^9/L
+Platelets >= 100 x 10^9/L
+Platelets >= 100000/uL
+Platelets >= 100,000/mL
+Platelets >= 100,000/µL
+Platelets >= 100,000/ul
+Platelets > 100 K/uL
+Platelets > 100 K/uL
+Platelets > 125,000 cells/ul within 14 days prior to treatment initiation
+Platelets >100,000/µl
+Platelets (Plts) >= 50,000/uL
+Platelets >= 75,000/uL
+Platelets >= 50 x 10^3/uL
+Platelets >= 100 X 10^9/L
+Platelets < 25.000/µL.
+Platelets >= 50,000
+Platelets >= 100 X 10^9/L
+Platelets >= 100,000/uL
+Platelets >= 100,000/uL
+Platelets >= 100,000/ul
+Hematology: ANC ? 1.5X109/L; Platelets >100x109/L.
+Platelets < 75,000/ microliter
+Platelets >= 100 x 10^9/L
+Platelets >= 100,000/mL
+Platelets < 125,000/µL
+Platelets >= 75,000/uL
+Platelets >= 100 x 10^3/uL
+Platelets >= 30,000/ul
+Platelets < 100 x 10^9/L
+Platelets (PLT) >= 75,000/uL
+Platelets > 100,000/ml
+Platelets > 100,000/ul
+Platelets >= 75 x 10^9/L
+Platelets > 100,000/uL
+Platelets (PLT) >= 90 x 10^9/L without transfusions
+Platelets >= 100 x 10^9/L
+Platelets >= 75 x 10^3/uL
+Platelets > 100,000/uL
+Platelets >= 75,000
+Platelets >= 100 x 10^9/L
+Platelets (plts) > 90,000
+Platelets > 100,000/uL
+Platelets >= 150,000/uL
+Platelets >= 100,000/microliter
+Platelets >= 100,000/uL
+Patients with platelets >= 100,000/uL (without platelets transfusion for at least one week prior to blood test date); the most recent platelets level taken within 60 days prior to study enrollment will be considered
+Within 30 days of surgery: Platelets >= 100,000/ml
+Platelets >= 100,000 cells/L
+Platelets less than 50,000 within 6 months prior to study enrollment or
+Platelets > 100,000 cells/ul
+Platelets >= 100,000
+Platelets >= 100 x 10^3/uL, obtained within 14 days of the first dose of study drug
+Platelets >= 100 x 10^9/L
+Platelets >= 125 x 10^9/L (for Arm L pembrolizumab and Arm M nivolumab and expansion cohorts for all arms, platelets >= 100 x 10^9/L)
+Platelets >= 100,000/uL
+Platelets >= 100 x 10^9/L
+Platelets >= 20,000/ul without growth factor or transfusional support
+Platelets < 50 H K/UL in the past 30 days
+Platelets >= 100,000/ml
+Platelets >= 20,000/ul without growth factor or transfusional support
+Platelets >= 100,000/ml (within 30 days of surgery)
+Platelets > 50,000
+Platelets < 50 H K/UL in the past 30 days
+Platelets >= 100,000/microliter
+Platelets >= 50 B/L (10^9/L)
+Platelets >= 100,000/microliter
+Platelets ? 75,000/?L
+Platelets >= 50,000/uL
+Platelets >= 100,000/microliter
+Platelets >= 100,000/microliter
+Platelets >= 50,000/microliter
+Platelets >= 100,000/microliter
+Platelets >= 100,000/microliter
+Platelets >= 150,000/microliter
+Platelets >= 100,000/uL
+Platelets >= 100,000/microliter
+Platelets >= 100,000/microliter
+Platelets >= 75,000 / uL
+Platelets >= 100,000/microliter
+Platelets >= 100,000/microliter
+Platelets >= 100,000/uL
+Platelets > 50,000/uL
+Platelets >= 100,000/microliter
+Platelets >= 100 B/L (10^9/L)
+Platelets >= 75 x 10^9/L
+Within 30 days of eligibility confirmation: Platelets >= 50,000/uL
+Platelets >= 100 x 10^9/L
+Platelets ? 75 x 10?/L
+Platelets ? 100 x 109/L
+Platelets (plt) ? 75,000/uL
+Platelets >= 100 x 10^9/L
+Platelets >= 75,000/uL
+Platelets >= 100 x 109/L
+Platelets >= 100 x 10^9/L
+Platelets >= 100,000
+Platelets >= 75,000 cells/uL
+Platelets >= 75,000 cells/uL
+Platelets > 100,000 cells/uL
+Platelets > 50,000/uL
+Platelets > 100,000/uL
+Platelets >= 75,000 cells/uL
+Platelets >= 100 x 10^9/L
+Platelets < 100,000/?L
+Platelets >= 100,000/mL
+Platelets < 75,000/uL
+Platelets >= 100,000/uL
+Platelets >= 100 x 10^9/L
+Platelets > 50,000
+Platelets > 100,000/ul
+Platelets >= 100 x 10^9/L
+Platelets ? 30,000/uL
+Platelets >= 75 X 10^9/L
+Thrombocytopenia (platelets < 100,000 cells/uL)
+Platelets ? 100 x 10E9/L
+Platelets <75 x 109/L
+Platelets > 100 x 109/L,
+Platelets ?100 x 109/L